sRAGE was positively correlated with prohepcidin and the indicators for the assessment of autoimmune status (RF and anti-CCP antibodies), bone resorption (sRANKL), and inflammation (CRP and IL-6) only in the ACD subgroup (sTfR-F index < 1.5). Here, IL6 is linked to granular corneal dystrophy type II.